Campath Could Be Approved For Multiple Sclerosis By 2009, Genzyme Says
Genzyme CEO Termeer predicts the approval process will take three to four years following the halting of a Phase II trial in MS because of safety concerns.
Genzyme CEO Termeer predicts the approval process will take three to four years following the halting of a Phase II trial in MS because of safety concerns.